Dr. Hudis on Neoadjuvant Treatment of HER2-Positive Breast Cancer
November 23rd 2015
Clifford A. Hudis, MD, FACP, chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, takes a deeper look at neoadjuvant treatment for patients with HER2-positive breast cancer.